Isabel Bilbao
Overview
Explore the profile of Isabel Bilbao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Unanue-Arza S, Solis-Ibinagagoitia M, Diaz-Seoane M, Mosquera-Metcalfe I, Idigoras I, Bilbao I, et al.
Eur J Public Health
. 2020 Dec;
31(2):346-355.
PMID: 33313657
Background: Colorectal cancer (CRC) screening programmes require high levels of participation in order to reduce mortality. To improve participation rates, it is necessary to identify the health risk factors and...
2.
Portillo I, Idigoras I, Bilbao I, Arana-Arri E, Fernandez-Landa M, Hurtado J, et al.
Endosc Int Open
. 2018 Sep;
6(9):E1149-E1156.
PMID: 30211306
To compare the quality of colonoscopy in a population-based coordinated program of colorectal cancer screening according to type of hospital (academic or non-academic). Consecutive patients undergoing colonoscopy after positive FIT...
3.
Fernandez-Landa M, Aginagalde A, Arana-Arri E, Bujanda L, Idigoras I, Bilbao I, et al.
Gastroenterol Hepatol
. 2018 Sep;
42(2):73-81.
PMID: 30170708
Introduction: Colonoscopy is the diagnostic/therapeutic confirmation test for colorectal cancer. The monitoring of the experience of people who have undergone the test is interesting to improve the quality of the...
4.
Arana-Arri E, Imaz-Ayo N, Fernandez M, Idigoras I, Bilbao I, Bujanda L, et al.
United European Gastroenterol J
. 2018 Aug;
6(5):755-764.
PMID: 30083338
Background: Screening by means of biennial fecal occult blood test has provided a reduction in overall colorectal cancer mortality. Notwithstanding, we should not underestimate the harms that it can produce....
5.
Portillo I, Arana-Arri E, Gutierrez-Ibarluzea I, Bilbao I, Hurtado J, Sarasqueta C, et al.
Eur J Public Health
. 2018 Jul;
28(6):1143-1148.
PMID: 29982586
Background: The overall aim of this study was to describe trends in participation rates and detection of lesions in a colorectal cancer (CRC) screening programme, during three rounds, using faecal...
6.
Portillo I, Arana-Arri E, Idigoras I, Bilbao I, Martinez-Indart L, Bujanda L, et al.
World J Gastroenterol
. 2017 May;
23(15):2731-2742.
PMID: 28487610
Aim: To assess proportions, related conditions and survival of interval cancer (IC). Methods: The programme has a linkage with different clinical databases and cancer registers to allow suitable evaluation. This...